LENZ Therapeutics, Inc. OTC Markets
Equities
GRPH
US52635N1037
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
22.26 USD | -2.75% | +3.58% | +21.37% |
Mar. 27 | Piper Sandler Initiates LENZ Therapeutics at Overweight With $28 Price Target | MT |
Mar. 25 | LENZ Therapeutics, Inc.(NasdaqGS:LENZ) added to NASDAQ Composite Index | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
+2.73% | 108B | |
+9.59% | 104B | |
+6.58% | 23.66B | |
-12.59% | 22.1B | |
-3.29% | 19.71B | |
-35.36% | 18.2B | |
-13.29% | 16.19B | |
+4.68% | 13.72B | |
+34.25% | 12.22B |
- Stock
- Equities
- Stock LENZ Therapeutics, Inc.
- Stock LENZ Therapeutics, Inc. - OTC Markets
- News LENZ Therapeutics, Inc.
- BTIG Starts Graphite Bio at Buy With $18 Price Target